Immune Checkpoint Inhibitors
Opportunities and Challenges with Adoption of Immuno-Oncology Drugs and Diagnostics
Checkpoint Inhibitor I-O drugs in the market In cancer, immune checkpoint pathways are often activated to inhibit the nascent anti-tumor immune response. Immune checkpoint therapies
March 23, 2021
No Comments